Status:
COMPLETED
Efficacy and Safety of Metoprolol Succinate Prolonged-Release Tablet in Patients With Mild to Moderate Hypertension
Lead Sponsor:
AstraZeneca
Conditions:
Hypertension
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
This is an open-label, non-comparative, multi-centre clinical study to evaluate the Efficacy and safety of Metoprolol Succinate prolonged-release tablet (Betaloc Zok) in patients with mild to moderate...
Eligibility Criteria
Inclusion
- Provision of written informed consent
- Newly diagnosed essential hypertension who have not received anti- hypertensive treatment, or patients without antihypertensive medication in two weeks before screening, 90mmHg\<SiDBP \<110mmHg and SiSBP \<180mmHg.
Exclusion
- Known or suspected secondary hypertension
- Resting HR is \< 55bpm.
- Sick sinus syndrome
- Atrioventricular block of first degree (with P-R\>0.24seconds), or second or third degree
Key Trial Info
Start Date :
October 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2006
Estimated Enrollment :
310 Patients enrolled
Trial Details
Trial ID
NCT00861016
Start Date
October 1 2005
End Date
May 1 2006
Last Update
March 13 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.